NO20002962D0 - FremgangsmÕte for fremstilling av fludarabinfosfatlium-, - natrium-, -kalium-, -kalsium- og -magnesiumsalter, fremgangsmÕte for rensing av fludarabinfosfat, og fludarabinfosfat som er minst 99,5% rent - Google Patents

FremgangsmÕte for fremstilling av fludarabinfosfatlium-, - natrium-, -kalium-, -kalsium- og -magnesiumsalter, fremgangsmÕte for rensing av fludarabinfosfat, og fludarabinfosfat som er minst 99,5% rent

Info

Publication number
NO20002962D0
NO20002962D0 NO20002962A NO20002962A NO20002962D0 NO 20002962 D0 NO20002962 D0 NO 20002962D0 NO 20002962 A NO20002962 A NO 20002962A NO 20002962 A NO20002962 A NO 20002962A NO 20002962 D0 NO20002962 D0 NO 20002962D0
Authority
NO
Norway
Prior art keywords
fludarabine
fludarabine phosphate
phosphatlium
purification
potassium
Prior art date
Application number
NO20002962A
Other languages
English (en)
Other versions
NO315324B1 (no
NO20002962L (no
Inventor
Ulf Tilstam
Thomas Schmitz
Klaus Nickisch
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7852365&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20002962(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20002962D0 publication Critical patent/NO20002962D0/no
Publication of NO20002962L publication Critical patent/NO20002962L/no
Publication of NO315324B1 publication Critical patent/NO315324B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/19—Purine radicals with arabinosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20002962A 1997-12-11 2000-06-09 Fremgangsmate for fremstilling av fludarabinfosfatlitium-, - natrium-, -kalium-, -kalsium- og -magnesiumsalter, fremgangsmate for rensing avfludarabinfosfat, og fludarabinfosfat som er minst 99,5% rent NO315324B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19756289 1997-12-11
PCT/EP1998/007651 WO1999029710A2 (de) 1997-12-11 1998-11-30 Reinigungsverfahren zur herstellung von fludarabin-phosphat

Publications (3)

Publication Number Publication Date
NO20002962D0 true NO20002962D0 (no) 2000-06-09
NO20002962L NO20002962L (no) 2000-06-09
NO315324B1 NO315324B1 (no) 2003-08-18

Family

ID=7852365

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002962A NO315324B1 (no) 1997-12-11 2000-06-09 Fremgangsmate for fremstilling av fludarabinfosfatlitium-, - natrium-, -kalium-, -kalsium- og -magnesiumsalter, fremgangsmate for rensing avfludarabinfosfat, og fludarabinfosfat som er minst 99,5% rent

Country Status (21)

Country Link
US (2) US6046322A (no)
EP (1) EP1047704B2 (no)
JP (2) JP4261051B2 (no)
KR (2) KR100532898B1 (no)
AT (2) ATE231880T1 (no)
AU (1) AU739574B2 (no)
CA (1) CA2313486A1 (no)
CZ (1) CZ296366B6 (no)
DE (2) DE29825173U1 (no)
DK (1) DK1047704T4 (no)
ES (1) ES2190136T5 (no)
HK (1) HK1033831A1 (no)
HU (1) HU226997B1 (no)
IL (1) IL136283A (no)
NO (1) NO315324B1 (no)
PL (1) PL195712B1 (no)
SI (1) SI1047704T2 (no)
SK (1) SK283475B6 (no)
TW (1) TW424093B (no)
WO (1) WO1999029710A2 (no)
ZA (1) ZA9811338B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2313486A1 (en) 1997-12-11 1999-06-17 Schering Aktiengesellschaft Purification method for producing fludarabin phosphate
KR100381930B1 (ko) * 2000-03-16 2003-04-26 (주)바이오니아 유전자 변형 농산물 검출방법 및 검출용 프라이머
CA2469491A1 (en) 2001-12-12 2003-06-19 Kerrie Setiawan Composition for viral preservation
DE10164510A1 (de) * 2001-12-20 2003-07-10 Schering Ag Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes
CA2487070A1 (en) * 2002-05-24 2003-12-04 Sicor Inc. Aqueous fludarabine phosphate composition
EP1464708A1 (en) * 2003-04-03 2004-10-06 Pro. Bio. Sint. S.p.A. A process for the preparation of fludarabine phosphate from 2-fluoroadenine
US7698201B2 (en) * 2006-09-14 2010-04-13 The Prudential Insurance Company Of America Financial instrument utilizing an optional benefit election
CN103040855B (zh) * 2012-12-28 2014-05-14 海南锦瑞制药股份有限公司 一种磷酸氟达拉滨的药物组合物及其制备方法
EP3342778B1 (en) * 2015-08-28 2022-01-12 Zhejiang Hisun Pharmaceutical Co., Ltd. Crystal form of fludarabine phosphat, preparation method therefor, and application thereof
CN109265505A (zh) * 2018-09-12 2019-01-25 连云港杰瑞药业有限公司 一种磷酸氟达拉滨异构体杂质的合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756704A (fr) * 1969-09-26 1971-03-01 Parke Davis & Co Procede de production du 5'-phosphate de 9-(beta-d- arabinofuranosyl) adenine et de ses sels
US4188378A (en) * 1978-01-04 1980-02-12 The United States Of America As Represented By The Department Of Health, Education And Welfare Anticancer and antiviral activity of 9-β-D-arabinofuranosyl-2-fluoroadenine
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
US4357324A (en) * 1981-02-24 1982-11-02 The United States Of America As Represented By The Department Of Health And Human Services Prodrug derivatives of 9β-D-arabinofuranosyl-2-fluoroadenine
DE3323621A1 (de) 1982-07-08 1984-03-01 Yamasa Shoyu K.K., Choshi, Chiba Pharmazeutisches praeparat mit die antitumor-wirkung verstaerkender wirkung, ein solches praeparat enthaltende chemotherapeutische zusammensetzung und verwendung des praeparates zur unterstuetzung der antitumor-behandlung beim menschen und tier
US5110919A (en) * 1989-12-04 1992-05-05 Ash Stevens, Inc. Process for the preparation of 2-amino-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine and novel intermediates
DE69129971T2 (de) * 1990-06-27 1998-12-24 Ash Stevens Inc., Detroit, Mich. Verfahren zur herstellung von 9-beta-d-arabinofuranosyl-2-fluoroadenin 5'-phosphaten
US5602246A (en) 1992-11-25 1997-02-11 Schering Aktiengesellschaft Process for the preparation of fludarabine or fludarabine phosphate from guanosine
FR2701027B1 (fr) * 1993-02-01 1997-07-18 Warner Lambert Co Procede de synthese ameliore du 9-(beta-d-arabinofuranosyl)adenine 5'-phosphate.
DE19543052A1 (de) * 1995-11-06 1997-05-07 Schering Ag Verfahren zur Herstellung und Reinigung von Fludarabin-Phosphat und die Verwendung von sauren Ionenaustauschern im Verfahren
IT1276126B1 (it) 1995-11-14 1997-10-27 Archimica Spa Procedimento per la preparazine di 9-((2-idrossietossi)metil) guanina
CA2313486A1 (en) 1997-12-11 1999-06-17 Schering Aktiengesellschaft Purification method for producing fludarabin phosphate
US6174873B1 (en) 1998-11-04 2001-01-16 Supergen, Inc. Oral administration of adenosine analogs

Also Published As

Publication number Publication date
DE59807096D1 (de) 2003-03-06
AU739574B2 (en) 2001-10-18
WO1999029710A3 (de) 1999-09-10
HU226997B1 (en) 2010-04-28
IL136283A (en) 2006-10-31
DK1047704T4 (da) 2008-03-25
EP1047704B2 (de) 2007-11-07
EP1047704B1 (de) 2003-01-29
WO1999029710A2 (de) 1999-06-17
JP2009040797A (ja) 2009-02-26
PL341659A1 (en) 2001-04-23
DK1047704T3 (da) 2003-06-23
NO315324B1 (no) 2003-08-18
DE29825173U1 (de) 2005-12-22
US6046322A (en) 2000-04-04
TW424093B (en) 2001-03-01
JP2001525418A (ja) 2001-12-11
SI1047704T2 (sl) 2008-02-29
KR20010032919A (ko) 2001-04-25
HK1033831A1 (en) 2001-09-28
CA2313486A1 (en) 1999-06-17
ZA9811338B (en) 1999-06-10
AT8617U1 (de) 2006-10-15
HUP0100169A1 (hu) 2001-11-28
HUP0100169A3 (en) 2002-04-29
US7547776B1 (en) 2009-06-16
AU2155099A (en) 1999-06-28
JP4261051B2 (ja) 2009-04-30
ES2190136T3 (es) 2003-07-16
CZ20002159A3 (cs) 2000-09-13
IL136283A0 (en) 2001-05-20
KR100532898B1 (ko) 2005-12-05
SK283475B6 (sk) 2003-08-05
PL195712B1 (pl) 2007-10-31
EP1047704A2 (de) 2000-11-02
NO20002962L (no) 2000-06-09
SK8872000A3 (en) 2001-03-12
CZ296366B6 (cs) 2006-02-15
KR20050085937A (ko) 2005-08-29
SI1047704T1 (en) 2004-02-29
ES2190136T5 (es) 2008-03-01
ATE231880T1 (de) 2003-02-15

Similar Documents

Publication Publication Date Title
NO972214L (no) Fremgangsmåte for rensing og isolering av 2'-deoksy-2',2'-difluornukleosider
IL119839A (en) Process for the preparation of D,L-methionine or the salt thereof
ATE334993T1 (de) Hydratformen des natriumsalzes von alendronat, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese enthalten
IL141328A0 (en) Pantoprazole magnesium dihydrat
NO20002962D0 (no) FremgangsmÕte for fremstilling av fludarabinfosfatlium-, - natrium-, -kalium-, -kalsium- og -magnesiumsalter, fremgangsmÕte for rensing av fludarabinfosfat, og fludarabinfosfat som er minst 99,5% rent
IT8748394A0 (it) E la prevenzione della osteoporosi composizione di fluoro e calcio a e simili affezioni ossee lento rilascio, per il trattamento
BR9407743A (pt) Composiçao oral de peróxido de cálcio-bicarbonato
NO986086D0 (no) FremgangsmÕte for fremstilling av 17-estere av 9<alfa>,21-dihalo-pregnan-11
HU9800512D0 (en) Salts of bismuthum and antibiotica of the moenomycin group, process for producing them, their use and pharmaceutical compositions containing them
AU1945495A (en) Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds
NO964350L (no) Fremgangsmåte for fremstilling av magnesiumkloridgranuler
EE03393B1 (et) Protsess enantiomeerselt puhta asetidiin-2-karboksüülhappe saamiseks
KR970006169A (ko) 탄산칼슘의 제조방법
NL1000834C2 (nl) Werkwijze voor de bereiding van watervrij natriumcarbonaat.
PL335939A1 (en) Method of and system for obtaining 2,6-dichloro-5-fluoronicotinonitrile as well as monosodium salt of 3-cyano-2-hydroxy-5-fluoropyrid-6-one and its tautomers
HUP9904319A2 (hu) 3-Izopropil-2,1,3-benzotiadiazin-4-on-2,2-dioxid vagy sóinak szilárd keverékei
UA25568A (uk) Спосіб переробки калій, hатрій, магhій, кальцієвих важкорозчиhhих сульфатhих міhералів
NO994339D0 (no) Anvendelse av <alfa>1-surt glykoprotein ved fremstilling av et farmasöytisk preparat
NO20006393L (no) Enantiomerisk rene substituerte oksa-aza forbindelser, salter av de samme og fremgangsmåter for deres fremstilling
AUPO646097A0 (en) Production of potassium and calcium salts from saline wastewaters
PL346536A1 (en) Process for the preparation of calcium hydroxyalkane sulphonates
FI973836A0 (fi) Enfasig gipsbaeddsprocess foer produktion av kaliumsalter
ZA968383B (en) Composition for treatment of osteoporosis.
NO981135D0 (no) Syreaddisjonssalter av 2,3,4,5-tetrahydro-1H-3-benzazepinforbindelser
MX9706361A (es) Sales de carboxiamidas estables, de accion prolongada, composiciones que las contienen y el uso de las mismas.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees